EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigations of Some Chlorocresol Hydrazones Against Tyrosinase Enzyme by Molecular Docking Method: In Silico Study

Necla Kulabas, Fahrettin Bugra Kilic, Sevil Senkardes

Pharmedicine Journal · 2025

DOI: 10.62482/pmj.23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmedicine Journal, 2025. Verfasst von Necla Kulabas und 2 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Tyrosinase, found in various organisms, including plants and mammals, and is responsible for pigmentation as well as the undesirable browning of fruits and vegetables, is a multi-copper enzyme involved in the synthesis of melanin in human. As it is known, melanin provides protection against harmful ultraviolet radiation, which can lead to serious conditions like skin cancers. However, excessive melanin accumulation could result in hyperpigmented spots, creating aesthetic concerns. Tyrosinase inhibitors could potentially lead to the development of novel skin-whitening agents, anti-browning compounds for food preservation, and also for insect control substances. Recently, a wide spectrum of numerous moderate to potent tyrosinase inhibitors have been identified and reported.

Methods

In this study, by using the AutodockVina Virtual Screening Tool, some hydrazide-hydrazone compounds starting from p-chlorocresol were screened for interactions and binding mode of the tyrosinase active site. The enzyme-ligand interactions were analyzed using Biovia Discovery Studio software. Moreover, drug-likeness potential of the compounds was examined by using SwissADME online web tool.

Results

The results showed that compound S5, which did not violate the Lipinski and Veber rules and had a binding energy of -7.9 kcal/mol, could be a potential inhibitor of the tyrosinase enzyme.

Conclusion

Identifying the interactions between the tested ligands and the tyrosinase enzyme will contribute to the development of new hydrazide-hydrazone derivatives aiming the inhibition of tyrosinase.

Zitieren

APA

Kulabas, N., Kilic, F. B., & Senkardes, S. (2025). Investigations of Some Chlorocresol Hydrazones Against Tyrosinase Enzyme by Molecular Docking Method: In Silico Study. Pharmedicine Journal. https://doi.org/10.62482/pmj.23

Vancouver

Kulabas N, Kilic FB, Senkardes S. Investigations of Some Chlorocresol Hydrazones Against Tyrosinase Enzyme by Molecular Docking Method: In Silico Study. Pharmedicine Journal. 2025. doi:10.62482/pmj.23

BibTeX
@article{Kulabas2025,
  author = {Kulabas, Necla and Kilic, Fahrettin Bugra and Senkardes, Sevil},
  title = {Investigations of Some Chlorocresol Hydrazones Against Tyrosinase Enzyme by Molecular Docking Method: In Silico Study},
  journal = {Pharmedicine Journal},
  year = {2025},
  doi = {10.62482/pmj.23}
}
Kostenlos starten →